Cargando…
Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent
Recent findings have shown that aspirin, taken for several years, reduces the long-term risk of some cancers, particularly colorectal cancer. The result that aspirin benefit is detectable at daily low-doses (at least 75mg), the same used for the prevention of cardiovascular disease, positions the an...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816673/ https://www.ncbi.nlm.nih.gov/pubmed/24281340 http://dx.doi.org/10.3390/ph5121346 |